Obese Patients With Type 2 Diabetes

Phase 3

Completed

• Conditions: Obesity; Diabetes Mellitus, Non-Insulin-Dependent; Obesity in Diabetes

• Registration Number: NCT00029848
• Lead Sponsor: Sanofi

Brief Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Detailed Description

Not available

Study Timeline

• Study Start: 2001-10
• Study First Submitted: 2002-01-23
• Study First Submitted QC: 2002-01-23
• Study First Posted: 2002-01-24
• Primary Completion: 2004-05
• Study Completion: 2004-05
• Status Verified: 2009-04
• Last Update Submitted: 2009-04-17
• Last Update Posted: 2009-04-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1045

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in body weight

Secondary Outcome Measures

Name	Time	Method
Metabolic parameters

Trial Locations

Locations (43)

Innovative Clinical Trials; 🇺🇸 Birmingham, Alabama, United States

Lovelace Scientific Resources; 🇺🇸 Albuquerque, New Mexico, United States

Advanced Clinicla Therapeutics, LLC; 🇺🇸 Tucson, Arizona, United States

Southern California Prevention and Research Center Inc. (SPARC); 🇺🇸 Encino, California, United States

Anderson Clinical Research; 🇺🇸 San Bernardino, California, United States

Diablo Clinical Research, Inc.; 🇺🇸 Walnut Creek, California, United States

North East Clinical Research; 🇺🇸 Hamden, Connecticut, United States

Clinical Research of South Florida; 🇺🇸 Coral Gables, Florida, United States

Jackson Downey, MD; 🇺🇸 Jacksonville, Florida, United States

Jacksonville Center for Clinical Research; 🇺🇸 Jacksonville, Florida, United States

Scroll for more (33 remaining)